GLUE Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-11-16SCHEDULE 13G/A0001193125-26-464030SEC →
2026-11-16SCHEDULE 13G/A0000921895-26-003182SEC →
2026-11-16SCHEDULE 13G/A0000902664-26-004583SEC →
2026-11-16SCHEDULE 13G/A0000080255-26-000719SEC →
2026-11-0510-Q0001193125-26-448568SEC →
2026-11-058-K0001193125-26-448527SEC →
2026-10-0640001193125-26-415540SEC →
2026-10-018-K0001193125-26-409833SEC →
2026-09-088-K0001193125-26-384360SEC →
2026-08-14SCHEDULE 13G/A0000919574-26-005533SEC →
2026-08-14SCHEDULE 13G0000902664-26-003506SEC →
2026-08-0610-Q0001193125-26-336711SEC →
2026-08-068-K0001193125-26-336681SEC →
2026-07-1740001193125-26-307791SEC →
2026-07-161440001950047-26-007144SEC →
2026-07-1640001193125-26-306110SEC →
2026-07-151440001969223-26-000786SEC →
2026-07-08SCHEDULE 13G/A0000080255-26-000442SEC →
2026-07-0740001193125-26-297558SEC →
2026-07-0640001193125-26-296490SEC →
2026-07-06SCHEDULE 13D/A0001072613-26-000558SEC →
2026-07-0140001193125-26-292767SEC →
2026-06-301440001950047-26-006665SEC →
2026-06-3040001193125-26-290486SEC →
2026-06-3040001193125-26-290484SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Monte Rosa Therapeutics (GLUE) — Filings